Jul 08, 2019

GNS Among Ways Amgen is Applying AI to Combat Serious Illness

Wired magazine dove in to a few approaches Amgen is taking to using AI to combat serious illness and one of those ways is by partnering with GNS! Amgen, the world’s largest independent biotech company, is leading the charge in combining life sciences with data and technology to tackle the most serious diseases. Amgen is focusing on boosting the accuracy of risk predictions, making patient care more intuitive, using data to determine the most effective treatment for individual patients and supporting compliance through real time answers. By partnering with GNS, and through other initiatives, Amgen is living up to its mission of serving patients and leading the way biotech companies use technology in the process. Read the full article here.